The National Institutes of Health (NIH) is providing a $205,235 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the University of North Carolina at Chapel Hill (UNC-CH) for the "KUPAMBANA" intervention study. The study aims to address intersectional HIV and poverty stigmas and strengthen economic capabilities among young people living with HIV in Zambia, in order to improve HIV care continuum and mental health outcomes. The two-phase project will first adapt...
This federal Project Grant award for $783,348, granted by the National Institute of Nursing Research (NINR) under CFDA 93.361 Nursing Research program, supports the implementation and evaluation of a nurse-led, community-based intervention to increase equity in HIV clinical outcomes for heterosexual men who self-test in Tanzania. The key objectives of the project are to: 1) Tailor the STEP+CBNIMART intervention for heterosexual male self-testers, 2) Test the effectiveness of the intervention...
The federal Project Grant award F24AP02949 for $1,618,099.00 was provided by the U.S. Department of the Interior's Fish and Wildlife Service under the African Elephant Conservation Fund (CFDA 15.620) program. The purpose of this 4-year project is to support elephant conservation efforts in Zambia's Lower Zambezi National Park and surrounding areas. Key activities include: conducting ground, aerial and marine law enforcement and monitoring patrols; deploying 16 elephant satellite collars to track...
This federal Project Grant award, valued at $766,877.00 and issued by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research (CFDA 93.855) program, supports a randomized controlled trial to evaluate the efficacy of therapeutic drug monitoring (TDM) for linezolid in the treatment of rifampin-resistant tuberculosis (RR-TB). The primary goal is to determine if TDM can prevent premature discontinuation of linezolid, a critical medication for...
This Project Grant award, totaling $1,325,208.00, was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program. The grant funds a research study titled "Sequential Strategies to Reach and Reengage Individuals After Lapses from HIV Care in Zambia." The study aims to assess the effectiveness of different strategies for returning individuals with HIV treatment lapses to care and keeping them reengaged long-term. The key...
The Desmond Tutu Health Foundation received a $790,803 Project Grant from the National Institute of Allergy and Infectious Diseases within the Department of Health and Human Services. The grant supports the foundation's work to develop a method for gathering real-time data on factors influencing tuberculosis treatment adherence among men in South Africa. Specifically, the foundation will integrate modified ecological momentary assessments with medication event monitoring systems and assess the...
The Department of State Bureau of African Affairs awarded a $119,943 cooperative agreement to Family Development Initiatives LIMITED of Zambia to support a Community Led Monitoring Initiative to Improve Quality of HIV Care Services in Eastern Province from January 19, 2023 through November 30, 2023. The initiative will support community-based monitoring of HIV care services delivered through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program in Eastern Province, Zambia....
The U.S. Department of State's Bureau of African Affairs, under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program (CFDA 19.029), awarded a $105,000 Cooperative Agreement on March 18, 2024 to Grassroot Soccer Education Limited, a non-profit organization based in Zambia. The award supports community-led monitoring initiatives to improve the quality of HIV care in Zambia through client feedback collected by trained community members. The project aims to enhance HIV treatment...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,350,312 to develop a rapid phenotypic drug susceptibility testing system for tuberculosis (TB). The key products/services being delivered include: Developing and optimizing novel fluorescent trehalose probes (3HC-TRE and RMR-TRE) that can specifically detect live Mycobacterium tuberculosis (MTB) and...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $100,558 to Stellenbosch University in South Africa to conduct a series of prospective, multimodal cardiovascular research studies. The key objectives are to: 1) investigate the inflammatory pathways associated with heart muscle edema and fibrosis in people living with HIV (PLWH) by measuring and describing an extensive serum...